Syneron Medical (ELOS) Reports Q1 Adj-Loss of $0.23
Syneron Medical Ltd. (Nasdaq: ELOS) reports Q1 loss of $0.23, ex-items, versus the analyst estimate of ($0.16). Revenue for the quarter was $11.9 million, versus the consensus of $14.42 million.
You May Also Be Interested In
- UPDATE: Bristow Group (BRS) Reports Better-Than-Expected Q4 Results; Offers FY13 Outlook
- Pandora (P) Blows Up Expectations as Listener Hours Rip; Guides FY13 Ahead of Views
- Frontline (FRO) Posts Surprise Q1 Profit
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
